This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Lauras as. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Geir Langli: Innovator in Purine Nucleotide Derivatives
Introduction
Geir Langli is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of biochemistry, particularly through his innovative work on purine nucleotide derivatives. His research has implications for various applications in medicine and biotechnology.
Latest Patents
Langli holds a patent for "Purine nucleotide derivatives." This invention provides novel 8-carbyl substituted cAMPS and a novel procedure for the preparation of 8-Br-cAMP, which is a key starting material in biochemical research. His work in this area showcases his expertise and commitment to advancing scientific knowledge.
Career Highlights
Throughout his career, Geir Langli has demonstrated a strong dedication to research and innovation. His work has not only contributed to the scientific community but has also paved the way for future advancements in the field. He is currently associated with Lauras AS, where he continues to explore new avenues in biochemistry.
Collaborations
Langli has collaborated with esteemed colleagues such as Kjell Undheim and Kjetil Taskén. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Geir Langli is a prominent figure in the realm of biochemistry, with a focus on purine nucleotide derivatives. His innovative patent and collaborations highlight his contributions to the field. His work continues to inspire future research and development in biochemistry.